A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

PHASE3RecruitingINTERVENTIONAL
Enrollment

510

Participants

Timeline

Start Date

March 27, 2025

Primary Completion Date

June 1, 2028

Study Completion Date

November 1, 2029

Conditions
Esophageal Squamous Cell Carcinoma
Interventions
DRUG

Ifinatamab deruxtecan

Intravenous administration

DRUG

Docetaxel

Intravenous administration

DRUG

Paclitaxel

Intravenous administration

DRUG

Irinotecan hydrochloride (HCl)

Intravenous administration

Trial Locations (46)

833

RECRUITING

Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City

3722

RECRUITING

Severance Hospital, Yonsei University Health System, Seoul

5505

RECRUITING

Asan Medical Center, Seoul

6351

RECRUITING

Samsung Medical Center, Seoul

6591

RECRUITING

The Catholic University of Korea, Seoul St. Marys Hospital, Seoul

8308

RECRUITING

Korea University Guro Hospital, Seoul

10408

RECRUITING

National Cancer Center, Goyang-sisouth

11217

RECRUITING

Taipei Veterans General Hospital, Taipei

13620

RECRUITING

Seoul National University Bundang Hospital, Seongnam-si

13823

RECRUITING

Memorial Healthcare International S R L, Bucharest

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

21565

RECRUITING

Gachon University Gil Medical Center, Incheon

29609

RECRUITING

CHU Brest - Hôpital de la Cavale Blanche, Brest

38120

RECRUITING

Baptist Cancer Center, Memphis

40447

NOT_YET_RECRUITING

China Medical University Hospital, Taichung

48202

RECRUITING

Henry Ford Health System, Detroit

58128

RECRUITING

Chonnam National University Hwasun Hospital, Hwasun-gun

70403

RECRUITING

National Cheng Kung University Hospital, Tainan City

76104

RECRUITING

John Peter Smith Hospital, Fort Worth

100225

RECRUITING

National Taiwan University Hospital, Taipei

200542

RECRUITING

Centrul de Oncologie Sfantul Nectarie Craiova, Craiova

250117

RECRUITING

Shandong Cancer Hospital, Jinan

361004

RECRUITING

Zhongshan Hospital Xiamen University, Xiamen

407280

RECRUITING

S.C Radiotherapy Center Cluj S.R.L, Comuna Floresti

430022

RECRUITING

Union Hospital Tongji Medical College Huazhong University of Science and Technology, Wuhan

453000

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

453100

RECRUITING

The First Affiliated Hospital of Xinxiang Medical University, Weihui

610041

RECRUITING

Sichuan cancer hospital, Chengdu

720284

RECRUITING

S.C. Sigmedical Services SRL, Suceava

104-0045

RECRUITING

National Cancer Center Hospital, Chūōku

734-8551

RECRUITING

Hiroshima University Hospital, Hiroshima

277-8577

RECRUITING

National Cancer Center Hospital East, Kashiwa

761-0793

RECRUITING

Kagawa University Hospital, Kita-gun

650-0047

RECRUITING

Kobe City Hospital Organization Kobe City Medical Center General Hospital, Kobe

135-8550

RECRUITING

Cancer Institute Hospital of JFCR, Kōtoku

791-0280

RECRUITING

Shikoku Cancer Center, Matsuyama

464-8681

RECRUITING

Aichi Cancer Center, Nagoya

541-8567

RECRUITING

Osaka International Cancer Institute, Osaka

589-8511

RECRUITING

Kindai University Hospital, Ōsaka-sayama

362-0806

RECRUITING

Saitama Cancer Center, Saitama

060-8648

RECRUITING

Hokkaido University Hospital, Sapporo

160-8582

RECRUITING

Keio University Hospital, Shinjuku-ku

565-0871

RECRUITING

The University of Osaka Hospital, Suita-shi

411-8777

RECRUITING

Shizuoka Cancer Center, Sunto-gun

241-8515

RECRUITING

Kanagawa Cancer Center, Yokohama

700-721

RECRUITING

Kyungpook National University Chilgok Hospital, Daegu

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Daiichi Sankyo

INDUSTRY